Viewing Study NCT01332656


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-25 @ 9:26 PM
Study NCT ID: NCT01332656
Status: COMPLETED
Last Update Posted: 2015-12-21
First Post: 2011-04-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module